EGFR and neoplasm: The two highly EGFR-amplified cases also contained high-level focal amplicons targeting other well-known oncogenic pathways (Fig. 2), suggesting that additional co-occurring genomic lesions may contribute to PD-L1 overexpression in TNBC tumor cells.